Theranica, a prescribed neuromodulation therapeutics company, today announced Medicaid coverage for the Nerivio® REN wearable ...

A team of researchers has developed a soft cortical device that could revolutionize the treatment of epilepsy and other ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

A team led by Brigham and Women's Hospital identified a brain circuit that could be a potential target to treat PTSD in ...

NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq:HSDT) has announced promising preliminary findings from its PoNSTEP study, which evaluates the impact of adherence to the Portable ...

Researchers have identified specific brain lesions associated with reduced PTSD symptoms in veterans, providing a potential ...

Sensars, a pioneering medtech company, has stepped up to fill in this gap with its groundbreaking approach to neuromodulation ...

Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy® in Phase 2 and improvement in DGI scores from Phase ...

Axonics announced today that it received regulatory approval in Australia for its R20 rechargeable sacral neuromodulation ...

DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational UpdateAdditional clinical data on patients ...

However, there is a lack of knowledge about how externally applied currents affect neuronal spiking activity in cerebellar circuits in vivo. We investigated how Cb-tDCS affects the firing rate of ...

Researchers analyzed datasets to study brain circuitry that might be causally linked to PTSD in military veterans.